Very good chance they will get Vitiligo approved as another indication, valuation is ridiculously low if you start to price that in. Jefferies, out of all the analysts, did just that and came up with a PT ~$50.
All IMO DYOR
- Forums
- ASX - By Stock
- Disc Medicine - Best comparison stock to Clinuvel
Very good chance they will get Vitiligo approved as another...
-
-
- There are more pages in this discussion • 141 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.36 |
Change
0.010(0.07%) |
Mkt cap ! $719.1M |
Open | High | Low | Value | Volume |
$14.35 | $14.50 | $14.05 | $1.379M | 97.02K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6935 | $14.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.37 | 352 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6935 | 14.270 |
1 | 100 | 14.160 |
1 | 1111 | 14.110 |
1 | 32 | 14.100 |
1 | 674 | 14.080 |
Price($) | Vol. | No. |
---|---|---|
14.370 | 352 | 1 |
14.390 | 352 | 1 |
14.410 | 1484 | 2 |
14.480 | 400 | 1 |
14.600 | 50 | 1 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online